跳至主要内容
临床试验/NCT00768495
NCT00768495Unknown不适用

Evaluation of the Success of Endovascular Peripheral Revascularization for the Treatment of Chronic Limb Ischemia by Measuring OxyHb and DeoxyHb Using a New Hyperspectral Imaging Device (OxyVu).

HyperMed1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2008年10月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1

研究概览

简要总结

This trial will collect tissue oxygenation data via hyperspectral imaging before and after endovascular procedures.

详细描述

This will be a nonrandomized, nonblinded, prospective observational study to correlate the results obtained with the traditional measures of success of endovascular revascularization of peripheral arteries for the treatment of chronic limb ischemia; i.e., ABPI, PVR with oxyhemoglobin (OxyHb) and deoxyhemoglobin (DeoxyHb) measurements obtained with a new imaging device manufactured by HyperMed Inc (OxyVu) that uses hyperspectral technology.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with established diagnosis of lower limb ischemic based on their symptoms of claudication, rest pain, non-healing ulcers or gangrene and other vascular laboratory tests that are currently used to make this diagnosis and have been scheduled for endovascular revascularization.
  • Age group between 50-85
  • Gender - Male or Female
  • Race - all race and ethnicities

排除标准

  • Patients with known cardiac disease - new MI (within 3 months).
  • Patients with hypertension with the systolic BP >200 or diastolic BP>110 on the day of testing
  • Patients on supplemental O2 for chronic obstructive lung disease
  • Bed-ridden subjects - either due to chronic disability or neurological problems

研究者

发起方
HyperMed
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验